Physician
Krishnarao, Tangella
Krishnarao, Tangella was paid $1.79M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 16% of everything it billed.
33Billing provider infoKRISHNARAO, TANGELLA
CHAMPAIGN, IL 61820
CHAMPAIGN, IL 61820
33aNPI1396755914assigned 08/08/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.79M
24GClaims313,405
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#44 of 398
Median peer was paid$66K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,279 | $108K | |
| 2019 | 48,336 | $231K | |
| 2020 | 44,026 | $240K | |
| 2021 | 48,197 | $305K | |
| 2022 | 59,294 | $386K | |
| 2023 | 49,069 | $293K | |
| 2024incomplete | 40,204 | $225K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 16% | 14,323 | 9,292 | $290K |
| 80053 | Comprehensive metabolic panel | 14% | 48,389 | 34,073 | $247K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 60,290 | 39,146 | $183K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 5,258 | 4,066 | $180K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.1% | 8,736 | 7,312 | $73K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.0% | 8,459 | 4,147 | $72K |
| 84484 | 3.1% | 12,532 | 9,548 | $56K | |
| 83735 | 3.1% | 16,157 | 10,966 | $56K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.0% | 1,986 | 1,822 | $53K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.6% | 11,067 | 6,152 | $47K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 5,329 | 4,225 | $47K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.5% | 2,952 | 2,768 | $45K |
57 more codes
| 83880 | 2.5% | 4,181 | $44K | |
| 83690 | 2.2% | 11,467 | $40K | |
| 83605 | 2.2% | 7,837 | $40K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 1,585 | $34K |
| 81025 | 1.4% | 11,817 | $25K | |
| 81001 | 1.4% | 17,255 | $25K | |
| 82805 | 1.3% | 900 | $23K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 336 | $20K |
| 85610 | <1% | 8,897 | $18K | |
| 84702 | <1% | 3,159 | $16K | |
| 85379 | <1% | 3,681 | $14K | |
| 85730 | <1% | 4,489 | $14K | |
| 84703 | <1% | 3,822 | $13K | |
| 87807 | <1% | 1,952 | $12K | |
| 88342 | <1% | 459 | $10K | |
| 86140 | <1% | 4,233 | $10K | |
| 82550 | <1% | 3,316 | $10K | |
| 82150 | <1% | 2,549 | $9K | |
| 81003 | <1% | 7,246 | $8K | |
| 84100 | <1% | 3,091 | $7K | |
| 88307 | <1% | 112 | $6K | |
| 87210 | <1% | 2,237 | $6K | |
| 82140 | <1% | 1,281 | $5K | |
| 85027 | <1% | 1,729 | $5K | |
| 84550 | <1% | 2,081 | $4K | |
| 85652 | <1% | 2,430 | $3K | |
| 80076 | <1% | 611 | $2K | |
| 83615 | <1% | 702 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 49 | $2K |
| 85060 | <1% | 118 | $1K | |
| 88304 | <1% | 57 | $1K | |
| 84145 | <1% | 99 | $1K | |
| 85014 | <1% | 924 | $1K | |
| 85018 | <1% | 918 | $1K | |
| 87040 | <1% | 72 | $846.18 | |
| 82077 | <1% | 79 | $818.44 | |
| 82009 | <1% | 522 | $657.95 | |
| 80202 | <1% | 93 | $657.36 | |
| 82570 | <1% | 235 | $558.26 | |
| 82950 | <1% | 194 | $533.57 | |
| 86901 | <1% | 79 | $182.88 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 33 | $181.50 |
| 85045 | <1% | 155 | $179.47 | |
| 82272 | <1% | 156 | $178.82 | |
| 84439 | <1% | 41 | $158.64 | |
| 86780 | <1% | 16 | $138.24 | |
| 86850 | <1% | 50 | $137.78 | |
| 84300 | <1% | 55 | $118.72 | |
| 86900 | <1% | 64 | $109.95 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 34 | $103.50 |
| 84156 | <1% | 61 | $71.71 | |
| 83550 | <1% | 15 | $63.56 | |
| 80061 | Lipid panel | <1% | 39 | $53.40 |
| 83540 | <1% | 16 | $50.76 | |
| 85651 | <1% | 40 | $34.50 | |
| 86592 | <1% | 12 | $23.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 246 | $4.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.